Pamela Wapnick insider trades

Open-market stock purchases and sales by Pamela Wapnick, Chief Financial Officer at Metagenomi Therapeutics, Inc, from SEC Form 4 filings since Apr 1, 2024.

Recent trades

DateStockTradeValue
Jun 5, 2026MGX Metagenomi Therapeutics, IncSold$3.7K
Apr 1, 2026MGX Metagenomi Therapeutics, IncBought (not open market)—
Apr 1, 2026MGX Metagenomi Therapeutics, IncBought (not open market)—
Mar 5, 2026MGX Metagenomi Therapeutics, IncSold$2.5K
Dec 5, 2025MGX Metagenomi, IncSold$2.8K
Dec 1, 2025MGX Metagenomi, IncBought (not open market)$192K

Companies traded

  • MGX Metagenomi Therapeutics, Inc: 8 sales, last Jun 5, 2026

Get free alerts when Pamela Wapnick files a new trade →